Posts
Dermatology Market Update 2026: Second Bites, Regulatory Headwinds, and the Flight Toward Scale
PGP’s CEO Michael Kroin published an article in Dermatology Times providing an update on the state of private equity investment in dermatology heading into 2026.
The Key Takeaways from the article:
- Private equity groups are re-entering dermatology, focusing on clinical excellence and long-term stability, while navigating regulatory challenges in restrictive states.
- Larger, infrastructure-rich platforms are prioritized, with buyers favoring practices with revenue scale, multi-site density, and integrated ancillary services.
- Smaller dermatology groups must demonstrate growth potential or join existing platforms to attract investor interest.
- Dermatology remains a dynamic specialty, offering opportunities and challenges for practice owners navigating strategic decisions.
Interested in learning more about market insights, valuation trends, and strategic opportunities?
Speak to a Senior BankerNo obligation. Completely confidential.
On This Page
MARKET TRENDS
Latest Market Updates

2026 Plastic Surgery Market Update: Private Equity Consolidation is Continuing Across the Plastic Surgery Sector

Is 2026 a Good Time to Sell Your ASC? Valuation Trends, Buyer Demand & Strategic Options for Surgery Center Owners


Considering a healthcare transaction? Start with a confidential conversation.
Whether you are considering a recapitalization, merger, or full sale, or simply want to understand your options, PGP's senior bankers are ready to help.
"*" indicates required fields

